UCN-01 (7-Hydroxystaurosporine) Yields Complete Response in Some T-Cell Lymphoma Patients
News
A completed Phase 2 clinical trial in relapsed or refractory systemic Anaplastic Large Cell Lymphoma (ALCL) demonstrated that the experimental drug UCN-01 (7-hydroxystaurosporine) produced a complete clinical response in 18% ... Read more